Vaginal cancer is a rare but serious condition where malignant (cancerous) cells form in the tissues of the vagina. Research on vaginal cancer primarily focuses on early detection methods, such as Pap smears and HPV testing, to improve prognosis. Additionally, scientists investigate novel treatment modalities like targeted therapy and immunotherapy to enhance survival rates and reduce side effects compared to traditional approaches like surgery, radiation, and chemotherapy. Understanding the genetic and environmental factors contributing to vaginal cancer's development is also crucial for personalized treatment strategies. Collaborative efforts between researchers, healthcare professionals, and advocacy groups aim to raise awareness, improve screening protocols, and ultimately, mitigate the impact of vaginal cancer on women's health.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States